Immunoprotection against toxic biomarkers is retained during Parkinson's disease progression.

MLA

Gruden, Marina A., et al. “Immunoprotection against Toxic Biomarkers Is Retained during Parkinson’s Disease Progression.” Journal of Neuroimmunology, vol. 233, no. 1–2, Apr. 2011, pp. 221–27. EBSCOhost, https://doi.org/10.1016/j.jneuroim.2010.12.001.

APA

Gruden, M. A., Sewell, R. D. E., Yanamandra, K., Davidova, T. V., Kucheryanu, V. G., Bocharov, E. V., Bocharova, O. A., Polyschuk, V. V., Sherstnev, V. V., & Morozova-Roche, L. A. (2011). Immunoprotection against toxic biomarkers is retained during Parkinson’s disease progression. Journal of Neuroimmunology, 233(1–2), 221–227. https://doi.org/10.1016/j.jneuroim.2010.12.001

Chicago

Gruden, Marina A, Robert D E Sewell, Kiran Yanamandra, Tatyana V Davidova, Valery G Kucheryanu, Evgeny V Bocharov, Olga A Bocharova, Vsevolod V Polyschuk, Vladimir V Sherstnev, and Ludmilla A Morozova-Roche. 2011. “Immunoprotection against Toxic Biomarkers Is Retained during Parkinson’s Disease Progression.” Journal of Neuroimmunology 233 (1–2): 221–27. doi:10.1016/j.jneuroim.2010.12.001.